Toward identifying a cellular determinant of telomerase repression.

Normal human cells undergo an irreversible growth arrest after a limited number of cell divisions (1,2). In contrast, a hallmark of most cancer cells is their ability to divide an unlimited number of times. Lately, the importance of counteracting the limitations of normal cell growth as a cellular requirement for cancer progression has become appreciated (3–5). There is evidence for a genetic basis of cellular aging. Thus, somatic cell hybrids between immortal cancer cells and normal cells are mortal, demonstrating that cellular aging/senescence is dominant over immortality (6). These findings have been pursued in an attempt to identify specific genes regulating these processes. Microcell-mediated chromosome transfer has provided mounting evidence that there are several senescence-specific genetic pathways (7). In some instances, the introduction of specific chromosomes or genes into proliferating cells results in a rapid growth arrest, suggesting that a senescence-like stress response may quickly induce cell cycle checkpoints. In other instances, there is a significant delay after chromosome transfer until the growth arrest. Recent progress in understanding the basis for this latter observation is the subject of this editorial.

[1]  C. Cooper,et al.  Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells. , 1999, Journal of the National Cancer Institute.

[2]  J. Sedivy Can ends justify the means?: telomeres and the mechanisms of replicative senescence and immortalization in mammalian cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Lindblom,et al.  Loss of heterozygosity at chromosome 3p correlates with telomerase activity in renal cell carcinoma. , 1998, International journal of oncology.

[4]  M. Oshimura,et al.  Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence , 1998, Molecular carcinogenesis.

[5]  J. Shay,et al.  Telomerase in cancer: diagnostic, prognostic, and therapeutic implications. , 1998, The cancer journal from Scientific American.

[6]  S. Benchimol,et al.  Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span , 1998, Current Biology.

[7]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.

[8]  C. Reznikoff,et al.  Minimal deletion of 3p13→14.2 associated with immortalization of human uroepithelial cells , 1998, Genes, chromosomes & cancer.

[9]  R. Weinberg,et al.  hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization , 1997, Cell.

[10]  I. Wistuba,et al.  Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. , 1997, Cancer research.

[11]  T R Hughes,et al.  Reverse transcriptase motifs in the catalytic subunit of telomerase. , 1997, Science.

[12]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[13]  J. Campisi The biology of replicative senescence. , 1997, European journal of cancer.

[14]  M. Oshimura,et al.  Multiple pathways to cellular senescence: role of telomerase repressors. , 1997, European journal of cancer.

[15]  J. Sedat,et al.  Block in Anaphase Chromosome Separation Caused by a Telomerase Template Mutation , 1997, Science.

[16]  A. Gazdar,et al.  Telomerase in the early detection of cancer. , 1997, Journal of clinical pathology.

[17]  June Corwin,et al.  Telomerase Catalytic Subunit Homologs from Fission Yeast and Human , 1997 .

[18]  C. Meijer,et al.  Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q. , 1996, Oncogene.

[19]  J. Shay,et al.  Telomerase activity in human cancer. , 1996, Current opinion in oncology.

[20]  J. Shay,et al.  Telomerase activity in human germline and embryonic tissues and cells. , 1996, Developmental genetics.

[21]  H. Erdjument-Bromage,et al.  A Human Telomeric Protein , 1995, Science.

[22]  M. Oshimura,et al.  Restoration of the Cellular Senescence Program and Repression of Telomerase by Human Chromosome 3 , 1995, Japanese journal of cancer research : Gann.

[23]  et al.,et al.  The RNA component of human telomerase , 1995, Science.

[24]  M. S. Rhyu Telomeres, telomerase, and immortality. , 1995, Journal of the National Cancer Institute.

[25]  G. Morin Is telomerase a universal cancer target? , 1995, Journal of the National Cancer Institute.

[26]  Keiko Hiyama,et al.  Correlating telomerase activity levels with human neuroblastoma outcomes , 1995, Nature Medicine.

[27]  J. Shay,et al.  Forward: Aging and cancer: Are telomeres and telomerase the connection? , 2001 .

[28]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[29]  C B Harley,et al.  Telomere length predicts replicative capacity of human fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Sager Senescence as a mode of tumor suppression. , 1991, Environmental health perspectives.

[31]  J. Shay,et al.  Defining the molecular mechanisms of human cell immortalization. , 1991, Biochimica et biophysica acta.

[32]  C B Harley,et al.  Telomere loss: mitotic clock or genetic time bomb? , 1991, Mutation research.

[33]  H. Cooke,et al.  In vivo loss of telomeric repeats with age in humans. , 1991, Mutation research.

[34]  Robin C. Allshire,et al.  Telomere reduction in human colorectal carcinoma and with ageing , 1990, Nature.

[35]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[36]  R. Myers,et al.  Structure and variability of human chromosome ends , 1990, Molecular and cellular biology.

[37]  G. Morin The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats , 1989, Cell.

[38]  E. Blackburn,et al.  A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis , 1989, Nature.

[39]  V A Zakian,et al.  Structure and function of telomeres. , 1989, Annual review of genetics.

[40]  L. S. Cram,et al.  A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Carol W. Greider,et al.  Identification of a specific telomere terminal transferase activity in tetrahymena extracts , 1985, Cell.

[42]  T. Norwood,et al.  Dominance of the senescent phenotype in heterokaryons between replicative and post-replicative human fibroblast-like cells. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[43]  J. Watson Origin of concatemeric T7 DNA. , 1972, Nature: New biology.

[44]  A. Olovnikov [Principle of marginotomy in template synthesis of polynucleotides]. , 1971, Doklady Akademii nauk SSSR.

[45]  L. Hayflick THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.